Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events

被引:26
作者
Wu, Feitong [1 ,2 ,3 ]
Juonala, Markus [4 ,5 ]
Jacobs Jr, David R. [6 ]
Daniels, Stephen R. [7 ]
Kahonen, Mika [8 ,9 ]
Woo, Jessica G. [10 ,11 ]
Sinaiko, Alan R. [12 ]
Viikari, Jorma S. A. [4 ,5 ]
Bazzano, Lydia A. [13 ]
Burns, Trudy L. [14 ]
Steinberger, Julia [15 ]
Urbina, Elaine M. [11 ,16 ]
Venn, Alison J. [1 ]
Raitakari, Olli T. [17 ,18 ,19 ,20 ,21 ]
Dwyer, Terence [1 ,22 ,23 ]
Magnussen, Costan G. [1 ,2 ,17 ,18 ,19 ]
机构
[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
[2] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Univ Melbourne, Fac Med Dent & Hlth Sci, Baker Dept Cardiometabol Hlth, Melbourne, Vic, Australia
[4] Univ Turku, Dept Med, Turku, Finland
[5] Turku Univ Hosp, Div Med, Turku, Finland
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland
[10] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA
[11] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[12] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[13] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
[14] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA
[15] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA
[16] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[17] Univ Turku, Ctr Populat Hlth Res, Turku, Finland
[18] Turku Univ Hosp, Turku, Finland
[19] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[20] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland
[21] Univ Turku, InFLAMES Res Flagship, Turku, Finland
[22] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England
[23] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
基金
英国医学研究理事会; 芬兰科学院; 美国国家卫生研究院; 欧洲研究理事会;
关键词
atherosclerosis; epidemiology; lipoproteins; longitudinal studies; risk assessment; risk factors; HEART-FAILURE; UNITED-STATES; EXERCISE; ADHERENCE; RISK; INTERVENTION; GUIDELINES; CHILDREN; OUTCOMES; UTILITY;
D O I
10.1161/CIRCULATIONAHA.123.064296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non-high-density lipoprotein cholesterol (non-HDL- C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non-HDL-C and LDL- C levels with adult ASCVD events and determined whether non-HDL- C has better utility than LDL-C in predicting adult ASCVD events. METHODS: This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non-HDL- C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index. RESULTS: After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non-HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14-1.41] to 1.35 [95% CI, 1.13-1.60] per unit increase in the risk factor z score). Non-HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006-0.0102] and 0.0038 [95% CI, 0.0008-0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non-HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non-HDL- C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98-3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23-3.06]). CONCLUSIONS: Childhood non-HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non-HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non-HDL-C. These findings suggest that both non-HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non-HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
[41]   LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes [J].
Eliasson, B. ;
Gudbjoernsdottir, S. ;
Zethelius, B. ;
Eeg-Olofsson, K. ;
Cederholm, J. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (11) :1420-1428
[42]   Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia: Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol [J].
Ito, Matthew K. ;
McKenney, James M. ;
Brinton, Eliot A. .
JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (01) :S3-S8
[43]   Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol [J].
Contois, John H. ;
Langlois, Michel R. ;
Cobbaert, Christa ;
Sniderman, Allan D. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (15)
[44]   Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia [J].
Sun, Cathy J. ;
McCudden, Christopher ;
Brisson, Diane ;
Shaw, Julie ;
Gaudet, Daniel ;
Ooi, Teik C. .
JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (01)
[45]   HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events [J].
Rohatgi, Anand ;
Khera, Amit ;
Berry, Jarett D. ;
Givens, Edward G. ;
Ayers, Colby R. ;
Wedin, Kyle E. ;
Neeland, Ian J. ;
Yuhanna, Ivan S. ;
Rader, Daniel R. ;
de Lemos, James A. ;
Shaul, Philip W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (25) :2383-2393
[46]   Status of non-HDL-cholesterol and LDL-cholesterol among subjects with and without metabolic syndrome [J].
Khan, Sikandar Hayat ;
Asif, Naveed ;
Ijaz, Aamir ;
Manzoor, Syed Mohsin ;
Niazi, Najumusaquib Khan ;
Fazal, Nadeem .
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (04) :554-558
[47]   Modification of the association between alcohol drinking and non-HDL cholesterol by gender [J].
Wakabayashi, Ichiro ;
Groschner, Klaus .
CLINICA CHIMICA ACTA, 2009, 404 (02) :154-159
[48]   Non-HDL Cholesterol as a Metric of Good Quality of Care Opportunities and Challenges [J].
Virani, Salim S. .
TEXAS HEART INSTITUTE JOURNAL, 2011, 38 (02) :160-162
[49]   NON-HDL CHOLESTEROL LEVELS AND CAROTID PLAQUE IN PATIENTS WITH PSORIATIC ARTHRITIS [J].
Polina-Lugo, R. L. ;
Gonzalez-Melendez, A. ;
Garza-Flores, O. A. ;
Cardenas-de la Garza, J. A. ;
Colunga-Pedraza, I. J. ;
Azpiri-Lopez, J. R. ;
Galarza-Delgado, D. A. ;
Arvizu-Rivera, R. I. .
ANNALS OF THE RHEUMATIC DISEASES, 2025, 84
[50]   Prognostic Value of Non-HDL Cholesterol in COVID-19 Pneumonia [J].
Sivri, Fatih ;
Sencan, Mehtap ;
Ozturk, Serife Barcin ;
Marasli, Ayse Sema ;
Icen, Yahya Kemal ;
Akgullu, Cagdas .
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2023, 120 (06)